How Salivary Testing Can Detect Systemic Diseases Dr. Tina Saw

Did you know that your saliva could hold the key to detecting not just dental issues but also serious health conditions like diabetes and heart disease? Dr. Tina Saw, CEO of Oral Genome, is pioneering a transformation in how we approach healthcare through innovative salivary diagnostics that bridge the gap between dentistry and overall health.

Oral Genome’s rapid, affordable chairside testing delivers results in just 15 minutes, analyzing crucial biomarkers like MMP-8, P. gingivalis, and glucose levels to assess risks for periodontal disease, systemic conditions, and more. This breakthrough technology empowers dentists to diagnose conditions earlier, track treatment progress more effectively, and collaborate meaningfully with physicians, creating a more comprehensive healthcare experience for patients.

Dr. Saw envisions salivary testing becoming a standard of care, much like annual blood tests in medicine, shifting dentistry from a reactive to a preventive model. This paradigm shift has tremendous potential to reduce long-term healthcare costs, improve patient outcomes, and strengthen the vital connection between oral health and overall medical care, ultimately transforming the dental office into a powerful frontline for preventive healthcare.

The Think Oral Health podcast dives deep into the profound connection between oral and systemic health. Join hosts Mariya Filipova and Dr. Jonathan Levine as they explore groundbreaking perspectives with pioneering healthcare innovators, researchers, and clinicians.